Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane PRO vs Refresh Optive Mega-3 in Dry Eye
NCT06975891Phase 4Terminated
- Sponsor
- Scripps Poway Eyecare and Optometry
- Start
- May 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Systane PRO, Optive Advanced in dry eye syndrome (DED), sponsored by Scripps Poway Eyecare and Optometry. Started May 2025; status: terminated.
02
Drugs
Systane PROOptive Advanced
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06975891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06975891.